Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase 1 Bioavailability Study of Topriamate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults
This study has been completed.
Study NCT00701493   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: June 17, 2008   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsy
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Additional drug interventions recognized in this trial
Topiramate
More general drug interventions related to this trial
Anti-Obesity Agents
Anticonvulsants
Central Nervous System Agents
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services